Michael T. Lotze, MD, FACS

Michael T. Lotze, MD, FACS

Michael T. Lotze, MD, FACS is Professor of Surgery, Immunology, and Bioengineering; Director of the DAMP Laboratories at the UPMC Hillman Cancer Center within the University of Pittsburgh Medical Center Hillman Cancer Center. He is a long-time SITC enthusiast,...
Michal Besser, PhD

Michal Besser, PhD

Michal Besser, PhD, is a global expert in immunology, cell therapy, and translational medicine, boasting an 18-year career spanning both academia and industry. Michal serves as Chief Technology Officer at the Davidoff Comprehensive Cancer Center, Rabin Medical Center,...
Jason Bock, PhD

Jason Bock, PhD

Jason Bock, PhD, is a biotech leader with a track record of building organizations that translate cutting-edge science into impactful biologic therapies. In 2019, he joined MD Anderson to establish the Biologics Development group, an internal biotech initiative...
Shari Pilon-Thomas, PhD

Shari Pilon-Thomas, PhD

Shari Pilon-Thomas PhD is a Senior Member of the Immunology Department and Co-Director of the Center for Immunization and Infection Research in Cancer (CIIRC) at Moffitt Cancer Center. She currently serves as the Co-Chair of the SITC Cell Therapy Committee. She...
Chantale Bernatchez, PhD

Chantale Bernatchez, PhD

Chantale Bernatchez, Ph.D., is Head of Process Development at CTMC. With more than 20 years of experience in the fields of immunology and T-cell therapy, Dr. Bernatchez has been instrumental in advancing academic and biotechnology work in TIL (tumor-infiltrating...